229 related articles for article (PubMed ID: 22594672)
1. Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity.
El-Bassossy HM; Abo-Warda SM; Fahmy A
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):643-9. PubMed ID: 22594672
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Paramar AN; Balaraman R
Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
[TBL] [Abstract][Full Text] [Related]
3. Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production.
El-Bassossy HM; El-Fawal R; Fahmy A
Vascul Pharmacol; 2012; 57(5-6):194-200. PubMed ID: 22281732
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase inhibitors zopolrestat and ferulic acid alleviate hypertension associated with diabetes: effect on vascular reactivity.
Badawy D; El-Bassossy HM; Fahmy A; Azhar A
Can J Physiol Pharmacol; 2013 Feb; 91(2):101-7. PubMed ID: 23458193
[TBL] [Abstract][Full Text] [Related]
5. Chrysin and luteolin attenuate diabetes-induced impairment in endothelial-dependent relaxation: effect on lipid profile, AGEs and NO generation.
El-Bassossy HM; Abo-Warda SM; Fahmy A
Phytother Res; 2013 Nov; 27(11):1678-84. PubMed ID: 23296950
[TBL] [Abstract][Full Text] [Related]
6. Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Sorrentino SA; Bahlmann FH; Besler C; Müller M; Schulz S; Kirchhoff N; Doerries C; Horváth T; Limbourg A; Limbourg F; Fliser D; Haller H; Drexler H; Landmesser U
Circulation; 2007 Jul; 116(2):163-73. PubMed ID: 17592079
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
[TBL] [Abstract][Full Text] [Related]
8. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
Gaikwad AB; Viswanad B; Ramarao P
Pharmacol Res; 2007 May; 55(5):400-7. PubMed ID: 17369046
[TBL] [Abstract][Full Text] [Related]
9. Effects of ascorbic acid on impaired vascular reactivity in aortas isolated from age-matched hypertensive and diabetic rats.
Ajay M; Mustafa MR
Vascul Pharmacol; 2006 Aug; 45(2):127-33. PubMed ID: 16807125
[TBL] [Abstract][Full Text] [Related]
10. A study comparing the effects of rosiglitazone and/or insulin treatments on streptozotocin induced diabetic (type I diabetes) rat aorta and cavernous tissues.
Elçioğlu HK; Kabasakal L; Özkan N; Çelikel Ç; Ayanoğlu-Dülger G
Eur J Pharmacol; 2011 Jun; 660(2-3):476-84. PubMed ID: 21463620
[TBL] [Abstract][Full Text] [Related]
11. Relationship between protective effects of rosiglitazone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells.
Wang S; Jiang JL; Hu CP; Zhang XJ; Yang DL; Li YJ
Diabetes Metab Res Rev; 2007 Feb; 23(2):157-64. PubMed ID: 16770837
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
[TBL] [Abstract][Full Text] [Related]
13. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats.
Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R
Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716
[TBL] [Abstract][Full Text] [Related]
14. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
[TBL] [Abstract][Full Text] [Related]
15. Effects of rosiglitazone (a peroxysome proliferator-activated receptor gamma agonist) on the blood pressure and aortic structure in metabolically programmed (perinatal low protein) rats.
Torres TS; D'Oliveira Silva G; Aguila MB; de Carvalho JJ; Mandarim-De-Lacerda CA
Hypertens Res; 2008 May; 31(5):965-75. PubMed ID: 18712052
[TBL] [Abstract][Full Text] [Related]
16. [Effects of rosiglitazone on aortic function in rats with insulin resistant-hypertension].
Ling HY; Feng SD; Zhou SH; Wang BX; Liu XQ; Hu B
Sheng Li Xue Bao; 2005 Apr; 57(2):125-31. PubMed ID: 15830095
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin treatment restores vasoconstriction and the inhibitory effect of LPC on endothelial relaxation via affecting oxidizing metabolism in diabetic rats.
Ceylan A; Karasu C; Aktan F; Ozansoy G
Diabetes Nutr Metab; 2004 Aug; 17(4):203-10. PubMed ID: 15575340
[TBL] [Abstract][Full Text] [Related]
18. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R
Life Sci; 2006 Apr; 78(22):2615-24. PubMed ID: 16318863
[TBL] [Abstract][Full Text] [Related]
19. Effects of gemfibrozil treatment on vascular reactivity of streptozotocin-diabetic rat aorta.
Ozansoy G; Akin FB
J Pharm Pharmacol; 2004 Feb; 56(2):241-6. PubMed ID: 15005883
[TBL] [Abstract][Full Text] [Related]
20. Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation.
El-Bassossy HM; Abo-Warda SM; Fahmy A
Am J Chin Med; 2014; 42(5):1153-67. PubMed ID: 25169908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
